Performances of all my stocks YTD at the end of H1 2025 :NATAN'S PORTFOLIO: +31.8%S&P500: +5.5% $Robinhood(HOOD)$ +151% $TransMedics Group, Inc.(TMDX)$ +115% $B2Gold(BTG)$ +48% $Alibaba(BABA)$ +34% $Meta Platforms, Inc.(META)$ +26% $Advanced Micro Devices(AMD)$ +17% (sold at +56%) $PDD Holdings Inc(PDD)$ +8% $Edwards Lifesciences(EW)$ +6% $PayPal(PYPL)$ -13% $Regeneron

1) $Alibaba(BABA)$ The biggest ecommerce in the world with >$1T GMV and the leading cloud services provider in the accelerating China market at 14x Fwd PE. Natan's fair value: ~$162 (+32%)2) $TransMedics Group, Inc.(TMDX)$ Stock is down 15% from recent high and remains very undervalued. The company is innovating the transplants market and they plan to achieve 10k transplants in 2028.Natan's fair value: ~$174 (+45%)3) $PDD Holdings Inc(PDD)$ One of the fastest growing ecommerces in the world trading at 8X EV/FCF.Management proved many times its ability to deliver impressive growth and profitability in one of the most competitive market in the world.Natan's fair

Q1 2026 turned out to be my second worst quarter since 2022, with a -14.5% return. With many names down 30% in just one month, it was hard to do much better. My exposure to healthcare partially protected part of the portfolio. Given the numerous opportunities, I preferred to rotate that part of the healthcare allocation into more offensive stocks in order to take advantage of the current discounts. I’m extremely confident in my allocation and, based on my fair value estimates, I believe the portfolio can deliver a 24% CAGR over the next five years, a number from which a large part of my conviction comes. For SG users only, Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with unlimited trading on SG, HK, and US stocks, as well as ETFs.

$Monday.com Ltd.(MNDY)$ IS VERY UNDERVALUED 👇🏻PRICE TARGET: $230POTENTIAL UPSIDE: +59% ✅ASSUMPTIONS:LTM Revenue: $1.166B5Y Revenue CAGR: 18% 2030 Profit Margin: 20%2030 PE Ratio: 35 Shares outstanding: 0.0533BShares dilution: 0%/yearVALUATION:Q3 2030 $MNDY SHARE PRICE =1.166 * (1.18)^5 * 0.20 * 35 /[0.0533 * (1.00)^5] = 350$You can now choose the discount rate that you prefer, for Monday I want to use 11%ACTUAL PRICE: $145FAIR VALUE: $208PRICE TARGET (1Y): $230POTENTIAL UPSIDE: +59%EXPECTED RETURNS: 19.3%/yearDIVIDEND YIELD: - ImageFor SG users only, Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with unlimited trading on SG, HK, and US stocks, as well as ETFs.

These stocks are up +32.4% on average YTD vs +3.0% of S&P500 🤯1) $Alibaba(BABA)$ The biggest ecommerce in the world with >$1T GMV and the biggest cloud services provider in China at 12x Fwd PE. Natan's fair value: ~$162 (+34%)Image2) $TransMedics Group, Inc.(TMDX)$ Stock is up 2X YTD after the unjustified hard sell-off.The company is innovating the transplants market and they plan to achieve 10k transplants in 2028.Natan's fair value: ~$162 (+13%)Image3) $Meta Platforms, Inc.(META)$ Meta is my favorite big tech at current prices trading at 27X Fwd PE.The social networks giant is spending billion of $ in Capex to build their AI data centers.In my opinion Me